查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2003556

全球光疗市场：按光源、产品、终端用户和应用进行分析—市场规模、产业动态、机会分析和预测（2026-2035 年）

Global Light Therapy Market: Analysis By Light Type, Product, End User, Application -Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2026-2035
出版日期: | 出版商: Astute Analytica | 英文 240 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

全球光疗市场正经历稳定持续成长，反映出其作为有效治疗方法在医疗保健和健康领域的重要性日益凸显。预计到2025年，全球光疗市场规模将达到11.7422亿美元，并在未来十年内显着扩张，2035年将达到约19.4203亿美元。这一成长意味着2026年至2035年预测期间的复合年增长率（CAGR）为5.16%，显示全球对光疗技术的接受度和应用率正在不断提高。

推动这一上升趋势的主要因素有几个。其中一个主要成长动力是非侵入性和无药物治疗方法的日益普及，这得益于患者寻求更安全、更天然的传统药物疗法替代方案。光疗在治疗忧郁症和季节性情感障碍等精神疾病以及痤疮和干癣等各种皮肤疾病方面尤其受到关注。此外，光疗在疼痛管理方面的效用也日益受到认可，因为它可以在不增加长期用药风险的情况下缓解疼痛症状。

显着的市场趋势

在光疗市场，Signify（飞利浦）、Buehler 和 Drager 等一级企业脱颖而出，成为市场领导者。这些公司凭藉其丰富的经验和良好的声誉，赢得了利润盈利的医院合同，并维持着强大的全球分销网络。它们以创新和可靠性为基石，在临床环境中建立了值得信赖的光疗解决方案供应商形象。

同时，Joovv、Celluma 和 PlatinumLED 等二线公司被视为产业颠覆者，主要目标市场是「专业消费者」和家庭市场。这些数位原生品牌采用网红行销和直销等创新行销策略，有效绕过传统医疗通路，直接接触消费者。透过利用社交媒体平台和线上社区，这些公司建立了忠实的基本客群，这些客户重视个人光疗产品的便利性和易用性。

这些层级之间的竞争动态凸显了光疗市场格局的演变。一级企业继续主导机构销售，并与医疗服务提供者保持牢固的合作关係，而二级颠覆者则正在重新定义消费者使用和获取光疗解决方案的方式。这种市场两极化不仅推动了创新，也促使企业开发更广泛的产品系列，以满足专业和家庭应用的需求。

主要成长驱动因素

持续的精神健康危机，尤其是在2020年以来发生的一系列事件的加剧下，已成为光疗市场（特别是非药物光疗领域）成长的重要驱动力。重度忧郁症（MDD）和季节性情绪障碍（SAD）病例的激增，导致精神科治疗需求与现有精神健康服务供给之间出现严重失衡。这场危机促使患者和医疗服务提供者寻求不完全依赖传统药物疗法的替代治疗方法。

新机会的趋势

随着OLED贴片的问世，光疗的未来即将迎来重大变革。最尖端科技可望重新定义光生物调节（PBM）的治疗方式。与传统治疗方法需要患者长时间坐在笨重的面板前不同，OLED贴片提供了一种灵活、可穿戴的解决方案，可以直接贴在皮肤上。这些贴片旨在全天持续释放低剂量光疗能量，使治疗更无缝地融入患者的日常生活。这项创新有望显着提升光疗的便利性和可近性，使用户更容易坚持治疗方案。

优化障碍

光疗市场面临的日益严峻的威胁之一是高功率、无防护措施的LED设备的快速普及，这些设备对消费者构成重大安全风险。这些设备，特别是那些发射波长在415奈米附近的高辐照度蓝光和近红外光（NIR）的设备，如果直接照射到使用者的眼睛，被认为可能对视网膜造成光化学损伤。随着越来越多的消费者在缺乏适当指导或防护措施的情况下使用这些高功率设备，人们对这些风险的关注度正在不断提高，对不当使用危害的认识也不断增强。

目录

第一章执行摘要：全球光疗市场

第二章：报告概述

  • 研究框架
    • 研究目标
    • 市场的定义
    • 市场区隔
  • 调查方法
    • 市场规模估算
    • 定性研究
    • 量化研究
    • 初步调查受访者组成：依地区划分
    • 数据检验
    • 研究的先决条件

第三章：全球光疗市场概览

  • 产业价值链分析
    • 原物料供应商
    • LED模组和装置製造商
    • 医疗和保健设备组装公司
    • 分销管道
    • 最终用户
  • 产业展望
    • 对活肤日益增长的需求
    • 家用照光治疗设备的广泛应用
    • 扩大在疼痛和发炎治疗的应用
  • PESTLE分析
  • 波特五力分析
    • 供应商的议价能力
    • 买方的议价能力
    • 替代品的威胁
    • 新进入者的威胁
    • 竞争强度
  • 市场成长及前景
    • 市场收入估算与预测（2020-2035 年）
  • 市场吸引力分析
    • 依产品类型
  • 可执行的见解（分析师建议）

第四章：竞争对手仪錶板

  • 市场集中度
  • 企业市场占有率分析
  • 竞争对手分析与基准测试

第五章：全球光疗市场分析

  • 市场动态和趋势
    • 成长驱动因素
    • 抑制因子
    • 机会
    • 主要趋势
  • 市场规模及预测（2020-2035）
    • 副产品
    • 透过使用
    • 透过光源
    • 最终用户
    • 按地区

第六章：北美光疗市场分析

第七章：欧洲光疗市场分析

第八章：亚太光疗市场分析

第九章：中东和非洲光疗市场分析

第十章：南美光疗市场分析

第十一章：公司简介（公司概况、历史沿革、组织架构、主要产品组合、财务指标、主要客户/产业、主要竞争对手、SWOT 分析、联络方式和业务策略展望）

  • 全球公司
    • Beurer
    • BioPhotas
    • Daylight Company
    • Koninklijke Philips
    • Lumie
    • Naturebright
    • Northern Light Technologies
    • Verilux
    • Zepter International
    • Zerigo Health
    • 其他主要企业

第十二章附录

简介目录
Product Code: AA02261717

The global light therapy market is witnessing steady and sustained growth, reflecting its rising prominence as an effective treatment modality across various medical and wellness applications. Valued at USD 1,174.22 million in 2025, the market is projected to expand significantly over the next decade, reaching a valuation of approximately USD 1,942.03 million by 2035. This growth corresponds to a compound annual growth rate (CAGR) of 5.16% during the forecast period from 2026 to 2035, underscoring the increasing acceptance and integration of light therapy technologies worldwide.

Several key factors are driving this upward trajectory. One of the primary growth engines is the rising adoption of non-invasive and drug-free treatment options, which appeal to patients seeking safer and more natural alternatives to conventional pharmaceutical therapies. Light therapy has gained particular traction in managing mental health conditions such as depression and seasonal affective disorder, as well as in treating various skin disorders like acne and psoriasis. Additionally, its utility in pain management is becoming increasingly recognized, offering relief without the risks associated with long-term medication use.

Noteworthy Market Developments

In the light therapy market, Tier 1 companies, such as Signify (Philips), Beurer, and Draeger, stand out as market leaders, leveraging their extensive experience and established reputations to secure lucrative hospital contracts and maintain robust global distribution networks. These firms have built their success on a foundation of innovation and reliability, positioning themselves as trusted providers of light therapy solutions in clinical settings.

On the other hand, Tier 2 companies, including Joovv, Celluma, and PlatinumLED, are characterized as disruptors in the industry, primarily targeting the "prosumer" and home-use markets. These digital-native brands have adopted innovative marketing strategies, using influencer marketing and direct sales approaches to reach consumers directly, effectively bypassing traditional medical distribution channels. By leveraging social media platforms and online communities, these companies have successfully cultivated a loyal customer base that values the convenience and accessibility of light therapy products for personal use.

The competitive dynamics between these tiers highlight the evolving landscape of the light therapy market. While Tier 1 companies continue to dominate institutional sales and maintain strong relationships with healthcare providers, Tier 2 disruptors are redefining consumer engagement and access to light therapy solutions. This duality in the market not only fosters innovation but also encourages a broader range of product offerings, catering to both professional and home-use applications.

Core Growth Drivers

The ongoing mental health crisis, particularly exacerbated by the events following 2020, is a significant factor propelling growth in the light therapy market, especially in relation to non-pharmacological interventions. The surge in cases of Major Depressive Disorder (MDD) and Seasonal Affective Disorder (SAD) has resulted in a notable imbalance between the demand for psychiatric care and the available supply of mental health services. This crisis has prompted both patients and healthcare providers to seek alternative treatment options that do not rely solely on traditional pharmacological approaches.

Emerging Opportunity Trends

The future of light therapy is poised to be transformed by the emergence of OLED patches, a cutting-edge technology that promises to redefine how photobiomodulation (PBM) is delivered. Unlike traditional treatments that require patients to sit in front of bulky panels for fixed periods, OLED patches offer a flexible, wearable solution that adheres directly to the skin. These patches are designed to deliver low-dose, continuous light therapy throughout the day, allowing for a more seamless integration of treatment into patients' daily lives. This innovation has the potential to greatly enhance the convenience and accessibility of light therapy, making it easier for users to maintain consistent treatment regimens.

Barriers to Optimization

A growing concern threatening the light therapy market is the rapid proliferation of high-powered, unshielded LED devices, which pose significant safety risks to consumers. These devices, particularly those emitting high-irradiance blue light at around 415nm and near-infrared (NIR) light, have been linked to potential retinal photochemical injury when users are exposed directly to the eyes. Such risks are increasingly coming under scrutiny as more consumers adopt these powerful devices without proper guidance or protective measures, leading to heightened awareness about the dangers of improper use.

Detailed Market Segmentation

By Product, the handheld devices segment captured the largest market share within the light therapy market, reflecting a significant shift in how consumers access and engage with dermatological treatments. This growth is largely driven by the aggressive "consumerization" of clinical dermatology, which has made advanced skincare technologies more accessible and user-friendly for everyday consumers. Unlike bulky full-body panels or stationary light therapy stands that require dedicated space and longer treatment times, handheld devices-such as wands, combs, and spot-treatment units-offer portability, convenience, and targeted application.

By Application, the sleep disorder segment garnered substantial revenue within the light therapy market, reflecting a significant shift in consumer health priorities and medical understanding. This growth has been fundamentally driven by the global post-pandemic surge in insomnia cases, which highlighted the widespread impact of disrupted sleep patterns on mental and physical well-being. The pandemic's effects on daily routines, stress levels, and social interactions have contributed to a rise in sleep-related issues, prompting increased demand for effective, non-pharmaceutical treatments such as light therapy.

By End-Use, by 2026, the Home Healthcare segment has solidified its leading position in the light therapy market, marking a significant structural shift in how photomedicine is delivered and accessed. This transformation reflects a broader trend toward decentralizing healthcare from clinical settings to patients' homes, allowing individuals to take a more active role in managing their health and wellness. The convenience and accessibility of home-based light therapy devices have greatly expanded the market, making effective treatments available to a wider audience without the need for frequent clinical visits.

By Light Type, in the rapidly maturing light therapy market of 2026, the Red Light spectrum, which ranges from 600nm to 700nm, has firmly established itself as the leading segment in terms of revenue generation. This specific wavelength range has gained widespread recognition for its therapeutic benefits, driving strong demand across various medical and wellness applications. As a result, it now accounts for over 36% of the total market share, making it the most significant contributor to the industry's growth.

Segment Breakdown

By Product

  • Light Box
  • Floor and Desk Lamps
  • Handheld Devices
  • Light Visor
  • Dawn Simulator
  • Light Therapy Lamps

By Application

  • Psoriasis
  • Vitiligo
  • Eczema
  • Acne Vulgaris
  • SAD/Winter Blues
  • Sleeping Disorders

By Light Type

  • Blue Light
  • Red Light
  • White Light

By End User

  • Dermatology Clinics
  • Home Healthcare

By Region

  • North America
  • The U.S.
  • Canada
  • Mexico
  • Europe
  • Western Europe
  • The UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Western Europe
  • Eastern Europe
  • Poland
  • Russia
  • Rest of Eastern Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia & New Zealand
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East & Africa (MEA)
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of MEA
  • South America
  • Argentina
  • Brazil
  • Rest of South America

Geography Breakdown

  • North America holds a commanding 38% share of the global light therapy market, reflecting the region's advanced healthcare infrastructure and strong focus on innovation. This significant market presence is partly driven by the relatively high prevalence of psoriasis, affecting approximately 3% of the population, which has spurred demand for effective treatment options. The region's healthcare providers and consumers have rapidly embraced FDA-cleared LED-based phototherapy devices, which offer safe and efficient treatment alternatives.
  • In the United States, companies are at the forefront of developing AI-driven personalization features that enhance treatment efficacy and user experience. For example, VitalLight has pioneered app-controlled dosing systems, allowing patients to customize their phototherapy regimens with greater precision and convenience. Additionally, the U.S. market is witnessing the rise of combination therapies that merge traditional phototherapy with biologic drugs, providing improved outcomes for patients with chronic skin conditions.
  • The robust investment landscape further fuels growth in the region. In 2025 alone, venture capital firms invested approximately $280 million in photomedtech startups, signaling strong confidence in the sector's potential. This influx of funding supports research, product development, and market expansion, driving continuous improvements in light therapy technology. Beyond the United States, Canada contributes to the market by focusing on niche applications such as treating seasonal affective disorder (SAD) and eczema, particularly among the geriatric population. These specialized uses highlight the versatility of light therapy across different demographic groups and medical needs.

Leading Market Participants

  • Beurer
  • BioPhotas
  • Daylight Company
  • Koninklijke Philips
  • Lumie
  • Naturebright
  • Northern Light Technologies
  • Verilux
  • Zepter International
  • Zerigo Health
  • Other Prominent Players

Table of Content

Chapter 1. Executive Summary: Global Light Therapy Market

Chapter 2. Report Description

  • 2.1. Research Framework
    • 2.1.1. Research Objective
    • 2.1.2. Market Definitions
    • 2.1.3. Market Segmentation
  • 2.2. Research Methodology
    • 2.2.1. Market Size Estimation
    • 2.2.2. Qualitative Research
      • 2.2.2.1. Primary & Secondary Sources
    • 2.2.3. Quantitative Research
      • 2.2.3.1. Primary & Secondary Sources
    • 2.2.4. Breakdown of Primary Research Respondents, By Region
    • 2.2.5. Data Triangulation
    • 2.2.6. Assumption for Study

Chapter 3. Global Light Therapy Market Overview

  • 3.1. Industry Value Chain Analysis
    • 3.1.1. Raw Material Suppliers
    • 3.1.2. LED Module & Device Manufacturers
    • 3.1.3. Medical & Wellness Device Assemblers
    • 3.1.4. Distribution Channel
    • 3.1.5. End User
  • 3.2. Industry Outlook
    • 3.2.1. Rising demand for skin rejuvenation
    • 3.2.2. Expansion of home-use light therapy devices
    • 3.2.3. Increasing adoption in pain & inflammation therapy
  • 3.3. PESTLE Analysis
  • 3.4. Porter's Five Forces Analysis
    • 3.4.1. Bargaining Power of Suppliers
    • 3.4.2. Bargaining Power of Buyers
    • 3.4.3. Threat of Substitutes
    • 3.4.4. Threat of New Entrants
    • 3.4.5. Degree of Competition
  • 3.5. Market Growth and Outlook
    • 3.5.1. Market Revenue Estimates and Forecast (US$ Mn), 2020-2035
  • 3.6. Market Attractiveness Analysis
    • 3.6.1. By Product Type
  • 3.7. Actionable Insights (Analyst's Recommendations)

Chapter 4. Competition Dashboard

  • 4.1. Market Concentration Rate
  • 4.2. Company Market Share Analysis (Value %), 2025
  • 4.3. Competitor Mapping & Benchmarking

Chapter 5. Global Light Therapy Market Analysis

  • 5.1. Market Dynamics and Trends
    • 5.1.1. Growth Drivers
      • 5.1.1.1. Growing demand for non-invasive, drug-free treatment solutions is being driven
    • 5.1.2. Restraints
    • 5.1.3. Opportunity
    • 5.1.4. Key Trends
  • 5.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 5.2.1. By Product
      • 5.2.1.1. Key Insights
        • 5.2.1.1.1. Light Box
        • 5.2.1.1.2. Floor and Desk Lamps
        • 5.2.1.1.3. Handheld Devices
        • 5.2.1.1.4. Light Visor
        • 5.2.1.1.5. Dawn Simulator
        • 5.2.1.1.6. Light Therapy Lamps
    • 5.2.2. By Application
      • 5.2.2.1. Key Insights
        • 5.2.2.1.1. Psoriasis
        • 5.2.2.1.2. Vitiligo
        • 5.2.2.1.3. Eczema
        • 5.2.2.1.4. Acne Vulgaris
        • 5.2.2.1.5. SAD/Winter Blues
        • 5.2.2.1.6. Sleeping Disorders
    • 5.2.3. By Light Type
      • 5.2.3.1. Key Insights
        • 5.2.3.1.1. Blue Light
        • 5.2.3.1.2. Red Light
        • 5.2.3.1.3. White Light
    • 5.2.4. By End User
      • 5.2.4.1. Key Insights
        • 5.2.4.1.1. Dermatology Clinics
        • 5.2.4.1.2. Home Healthcare
    • 5.2.5. By Region
      • 5.2.5.1. Key Insights
        • 5.2.5.1.1. North America
          • 5.2.5.1.1.1. The U.S.
          • 5.2.5.1.1.2. Canada
          • 5.2.5.1.1.3. Mexico
        • 5.2.5.1.2. Europe
          • 5.2.5.1.2.1. Western Europe
            • 5.2.5.1.2.1.1. The UK
            • 5.2.5.1.2.1.2. Germany
            • 5.2.5.1.2.1.3. France
            • 5.2.5.1.2.1.4. Italy
            • 5.2.5.1.2.1.5. Spain
            • 5.2.5.1.2.1.6. Rest of Western Europe
          • 5.2.5.1.2.2. Eastern Europe
            • 5.2.5.1.2.2.1. Poland
            • 5.2.5.1.2.2.2. Russia
            • 5.2.5.1.2.2.3. Rest of Eastern Europe
        • 5.2.5.1.3. Asia Pacific
          • 5.2.5.1.3.1. China
          • 5.2.5.1.3.2. India
          • 5.2.5.1.3.3. Japan
          • 5.2.5.1.3.4. South Korea
          • 5.2.5.1.3.5. Australia & New Zealand
          • 5.2.5.1.3.6. ASEAN
          • 5.2.5.1.3.7. Rest of Asia Pacific
        • 5.2.5.1.4. Middle East & Africa
          • 5.2.5.1.4.1. UAE
          • 5.2.5.1.4.2. Saudi Arabia
          • 5.2.5.1.4.3. South Africa
          • 5.2.5.1.4.4. Rest of MEA
        • 5.2.5.1.5. South America
          • 5.2.5.1.5.1. Argentina
          • 5.2.5.1.5.2. Brazil
          • 5.2.5.1.5.3. Rest of South America

Chapter 6. North America Light Therapy Market Analysis

  • 6.1. Market Dynamics and Trends
    • 6.1.1. Growth Drivers
    • 6.1.2. Restraints
    • 6.1.3. Opportunity
    • 6.1.4. Key Trends
  • 6.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 6.2.1. By Product
    • 6.2.2. By Application
    • 6.2.3. By Light Type
    • 6.2.4. By End-User
    • 6.2.5. By Country

Chapter 7. Europe Light Therapy Market Analysis

  • 7.1. Market Dynamics and Trends
    • 7.1.1. Growth Drivers
    • 7.1.2. Restraints
    • 7.1.3. Opportunity
    • 7.1.4. Key Trends
  • 7.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 7.2.1. By Product
    • 7.2.2. By Application
    • 7.2.3. By Light Type
    • 7.2.4. By End-User
    • 7.2.5. By Country

Chapter 8. Asia Pacific Light Therapy Market Analysis

  • 8.1. Market Dynamics and Trends
    • 8.1.1. Growth Drivers
    • 8.1.2. Restraints
    • 8.1.3. Opportunity
    • 8.1.4. Key Trends
  • 8.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 8.2.1. By Product
    • 8.2.2. By Application
    • 8.2.3. By Light Type
    • 8.2.4. By End-User
    • 8.2.5. By Country

Chapter 9. Middle East & Africa Light Therapy Market Analysis

  • 9.1. Market Dynamics and Trends
    • 9.1.1. Growth Drivers
    • 9.1.2. Restraints
    • 9.1.3. Opportunity
    • 9.1.4. Key Trends
  • 9.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 9.2.1. By Product
    • 9.2.2. By Application
    • 9.2.3. By Light Type
    • 9.2.4. By End-User
    • 9.2.5. By Country

Chapter 10. South America Light Therapy Market Analysis

  • 10.1. Market Dynamics and Trends
    • 10.1.1. Growth Drivers
    • 10.1.2. Restraints
    • 10.1.3. Opportunity
    • 10.1.4. Key Trends
  • 10.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 10.2.1. By Product
    • 10.2.2. By Application
    • 10.2.3. By Light Type
    • 10.2.4. By End-User
    • 10.2.5. By Country

Chapter 11. Company Profile (Company Overview, Company Timeline, Organization Structure, Key Product landscape, Financial Matrix, Key Customers/Sectors, Key Competitors, SWOT Analysis, Contact Address, and Business Strategy Outlook)

  • 11.1. Global Players
    • 11.1.1. Beurer
    • 11.1.2. BioPhotas
    • 11.1.3. Daylight Company
    • 11.1.4. Koninklijke Philips
    • 11.1.5. Lumie
    • 11.1.6. Naturebright
    • 11.1.7. Northern Light Technologies
    • 11.1.8. Verilux
    • 11.1.9. Zepter International
    • 11.1.10. Zerigo Health
    • 11.1.11. Other Prominent Players

Chapter 12. Annexure

  • 13.1 List of Secondary Sources
  • 13.2 Key Country Markets- Macro Economic Outlook/Indicators